IMAGE DESCTIPTION: Photo of a woman holding her head, representing brain fog. Photo of supplement pills in someone's hand. ME Association logo

The Daily Mail interviews Dr Charles Shepherd about supplement for brain fog and fatigue

On the 21st October, the Daily Mail published a new article, with the headline, “The ‘chemo' supplement that could beat brain fog and fatigue: Users swear by it… and now scientists share promising evidence it could actually help.”

Oxaloacetate is involved in chemical pathways that convert nutrients into cellular energy. New research has been done into its use in breast cancer survivors, but there have previously been studies into it's usage for people with ME/CFS and Long Covid. Dr Charles Shepherd, MEA Hon. Medical Adviser, was interviewed as part of this article, and we share below some notes on the key points Dr Shepherd made during the interview (which were not all published) on this supplement which you may find useful.

‘There's a positive theoretical reason why something like this might work,' he [Dr Charles Shepherd] says.
‘We need more information on it before drawing any conclusions, but my hope is that people who are capable of doing larger clinical trials will look at this and say, “yeah, this is worth following up”.'

Dr Charles Shepherd in The Daily Mail

Dr Charles Shepherd's interview notes:

Oxaloacetate – possible modes of action:

  • Oxaloacetate is involved in chemical pathways that convert nutrients into cellular energy
  • It may be involved it mitochondrial renewal. Mitochondria produce energy at a cellular level and mitochondrial dysfunction occurs in ME/CFS and LC
  • It may reduce inflammation in the brain – known as neuroinflammation
  • So there are some theoretical reasons as to why this food supplement could improve mental and physical fatigue in a number of conditions where these symptoms occur

ME/CFS trial results should be viewed with caution because:

  • Not placebo controlled
  • Smallish number of participants
  • Short duration – 6 weeks
  • Lack of objective outcome measures
  • No long term follow up
  • Commercial conflict of interest in funding

Breast cancer trial results should also be viewed with caution:

  • Again, small numbers, short duration, and not placebo controlled

Conclusions:

  • We need large randomised controlled trials that address all of the above concerns
  • We are not yet in a situation where this food supplement can be a recommended as a treatment for eirher physical or mental fatigue

Cautions:

  • Side-effects include gastrointestinal upsets, headaches and insomnia
  • Use with care in kidney disease
  • Commercial supplements are expensive

Dr Charles Shepherd,
Trustee and Hon. Medical Adviser to the ME Association,
Member of the 2018-2021 NICE guideline on ME/CFS committee,
Member of the 2002 Chief Medical Officer's Working Group on ME/CFS

Charles Shepherd

Further Media Coverage:

Previous MEA Coverage of Oxaloacetate:

Shopping Basket
Scroll to Top